Michael J. Costa

2.1k total citations
54 papers, 1.5k citations indexed

About

Michael J. Costa is a scholar working on Pulmonary and Respiratory Medicine, Reproductive Medicine and Surgery. According to data from OpenAlex, Michael J. Costa has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 13 papers in Reproductive Medicine and 11 papers in Surgery. Recurrent topics in Michael J. Costa's work include Sarcoma Diagnosis and Treatment (14 papers), Ovarian cancer diagnosis and treatment (13 papers) and Cervical Cancer and HPV Research (9 papers). Michael J. Costa is often cited by papers focused on Sarcoma Diagnosis and Treatment (14 papers), Ovarian cancer diagnosis and treatment (13 papers) and Cervical Cancer and HPV Research (9 papers). Michael J. Costa collaborates with scholars based in United States, Switzerland and Japan. Michael J. Costa's co-authors include Sharon W. Weiss, Judy Walls, Lawrence M. Roth, Randy Judd, Robin L. Davis, Patricia B. DeRose, John D. Trelford, Steven C. Campman, Lydia Howell and Mark E. Smith and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and International Journal of Cancer.

In The Last Decade

Michael J. Costa

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Costa United States 23 544 443 369 277 276 54 1.5k
Berit Hølund Denmark 21 223 0.4× 426 1.0× 345 0.9× 327 1.2× 73 0.3× 48 1.4k
J H Edmonson United States 23 753 1.4× 313 0.7× 1.0k 2.8× 159 0.6× 93 0.3× 45 1.8k
Anders Lindgren Sweden 19 386 0.7× 188 0.4× 695 1.9× 190 0.7× 83 0.3× 32 1.7k
Peter Craighead Canada 17 263 0.5× 169 0.4× 268 0.7× 412 1.5× 86 0.3× 54 1.2k
Lauren L. Ritterhouse United States 26 646 1.2× 453 1.0× 1.3k 3.4× 345 1.2× 272 1.0× 69 2.8k
JA Ledermann United Kingdom 24 439 0.8× 407 0.9× 904 2.4× 90 0.3× 39 0.1× 69 2.0k
James J. Burke United States 17 214 0.4× 674 1.5× 242 0.7× 984 3.6× 48 0.2× 27 1.6k
A Fanucchi Italy 24 181 0.3× 833 1.9× 420 1.1× 631 2.3× 32 0.1× 64 1.6k
Laurence Gladieff France 24 242 0.4× 657 1.5× 752 2.0× 421 1.5× 30 0.1× 135 1.9k
Lloyd K. Everson United States 16 382 0.7× 94 0.2× 978 2.7× 65 0.2× 69 0.3× 30 1.5k

Countries citing papers authored by Michael J. Costa

Since Specialization
Citations

This map shows the geographic impact of Michael J. Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Costa more than expected).

Fields of papers citing papers by Michael J. Costa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Costa. The network helps show where Michael J. Costa may publish in the future.

Co-authorship network of co-authors of Michael J. Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Costa. A scholar is included among the top collaborators of Michael J. Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Costa. Michael J. Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Costa, Michael J., Christian Bøge Lyndgaard, Judy Walls, & Sidney Scudder. (1999). Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21WAF1CIP1 predicts survival and good response to platinin-based chemotherapy. Human Pathology. 30(6). 640–647. 12 indexed citations
2.
Fink, Daniel, S Nebel, Paula S. Norris, et al.. (1998). Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. International Journal of Cancer. 77(5). 741–746. 64 indexed citations
3.
Costa, Michael J., C. Hansen, Allan W. Dickerman, & Sidney Scudder. (1998). Clinicopathologic Significance of Transitional Cell Carcinoma Pattern in Nonlocalized Ovarian Epithelial Tumors (Stages 2–4). American Journal of Clinical Pathology. 109(2). 173–180. 22 indexed citations
4.
Costa, Michael J., et al.. (1997). Inhibin immunohistochemistry applied to ovarian neoplasms: A novel, effective, diagnostic tool. Human Pathology. 28(11). 1247–1254. 68 indexed citations
7.
Costa, Michael J., et al.. (1995). Cervical carcinoma with glandular differentiation: Histological evaluation predicts disease recurrence in clinical stage I or II patients. Human Pathology. 26(8). 829–837. 37 indexed citations
8.
Costa, Michael J., Judy Walls, & John D. Trelford. (1995). c-erbB-2 Oncoprotein Overexpression in Uterine Cervix Carcinoma With Glandular Differentiation:A Frequent Event But Not an Independent Prognostic Marker Because It Occurs Late in the Disease. American Journal of Clinical Pathology. 104(6). 634–642. 36 indexed citations
9.
Costa, Michael J.. (1994). Pseudomyxoma peritonei. Histologic predictors of patient survival.. PubMed. 118(12). 1215–9. 31 indexed citations
11.
Costa, Michael J., et al.. (1994). Adenocarcinoma and Adenosquamous Carcinoma of the Uterine Cervix. International Journal of Surgical Pathology. 1(3). 181–189. 7 indexed citations
12.
Costa, Michael J., Patricia B. DeRose, Lawrence M. Roth, et al.. (1994). Immunohistochemical phenotype of ovarian granulosa cell tumors: Absence of epithelial membrane antigen has diagnostic value. Human Pathology. 25(1). 60–66. 86 indexed citations
13.
Costa, Michael J., et al.. (1993). Uterine Glandular Carcinoma. International Journal of Surgical Pathology. 1(1). 13–24. 7 indexed citations
14.
Costa, Michael J., William J. Thomas, Bhagirath Majmudar, Karlene Hewan‐Lowe, & Lawrence M. Roth. (1992). Ovarian Myxoma: Ultrastructural and Immunohistochemical Findings. Ultrastructural Pathology. 16(4). 429–438. 11 indexed citations
15.
Costa, Michael J., Robert Morris, Reginald W. Wilson, & Randy Judd. (1992). Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas. Human Pathology. 23(7). 787–797. 24 indexed citations
16.
Costa, Michael J., et al.. (1992). Cervicovaginal cytology in carcinosarcoma [malignant mixed mullerian (mesodermal) tumor] of the uterus. Diagnostic Cytopathology. 8(1). 33–40. 26 indexed citations
17.
Smith, Mark E., Michael J. Costa, & Sharon W. Weiss. (1991). Evaluation of CD68 and Other Histiocytic Antigens in Angiomatoid Malignant Fibrous Histiocytoma. The American Journal of Surgical Pathology. 15(8). 757–763. 55 indexed citations
18.
Costa, Michael J., et al.. (1991). Vaginocervical cytology in victims of sexual assault. Diagnostic Cytopathology. 7(4). 337–340. 5 indexed citations
19.
Hunter, Stephen, Karlene Hewan‐Lowe, & Michael J. Costa. (1990). Primary pulmonary α-fetoprotein-producing malignant germ cell tumor. Human Pathology. 21(10). 1074–1076. 4 indexed citations
20.
Borenstein, David, Michael J. Costa, Frank S. Jannotta, & Hugo V. Rizzoli. (1988). Localized isolated angiitis of the central nervous system associated with primary intracerebral lymphoma. Cancer. 62(2). 375–380. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026